Mitoxantrone Plus Gemcitabine in Pretreated Patients with Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Mitoxantrone Plus Gemcitabine in Pretreated Patients with Metastatic Breast Cancer

Published:2006-04 Issue:2 Volume:18 Page:192-198
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Onyenadum A.,Gogas H.,Kosmidis P.,Aravantinos G.,Bafaloukos D.,Bacoyiannis H.,Markopoulos C.,Koutras A.,Tzorakoelefterakis E.,Makatsoris T.,Fountzilas G.,Kalofonos H.P.

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference33 articles.

1. Cancer statistics, 2000

2. Salvage Chemotherapy for Metastatic Breast Cancer

3. Mitoxantrone (novantrone∗) as single agent and in combination chemotherapy in the treatment of advanced breast cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of laparoscopic radiofrequency ablation versus systemic therapy alone in the treatment of breast cancer metastasis to the liver;HPB;2013-10

2. Topoisomerase Inhibitors in Metastatic Breast Cancer: Overview of Current Practice and Future Development;Current Breast Cancer Reports;2013-01-03

3. Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy;Cancer Immunology, Immunotherapy;2011-08-27

4. A Phase I/II Study of Combined Chemotherapy with Mitoxantrone and Uracil/Tegafur for Advanced Hepatocellular Carcinoma;Japanese Journal of Clinical Oncology;2010-11-29